Literature DB >> 32808888

Quantitative Muscle MRI Depicts Increased Muscle Mass after a Behavioral Change in Myotonic Dystrophy Type 1.

Linda Heskamp1, Kees Okkersen1, Marlies van Nimwegen1, Marieke J Ploegmakers1, Guillaume Bassez1, Jean-Francois Deux1, Baziel G van Engelen1, Arend Heerschap1.   

Abstract

Background Patients with myotonic dystrophy type 1 (DM1) increased their physical activity and exercise capacity following a behavioral intervention. However, it is unknown what is altered in muscles of patients with DM1 as a result of this intervention. The increased exercise capacity suggests that decelerated fat infiltration or increased muscle cross-sectional area (CSA) could be involved. Purpose To assess the effect of this activity-stimulating behavioral intervention on the lower extremity muscles of patients with DM1 with longitudinal quantitative muscle MRI. Materials and Methods In this prospective trial, participants with DM1 were randomized to a behavioral intervention (n = 14) or continued regular care (standard care; n = 13); no age-matched pairing was performed. Participants underwent MRI of the lower extremities at baseline and 10-month follow-up (January 2015 to March 2016). Fat fraction (FF), muscle CSA, and muscle water T2 (T2water) as markers for fat infiltration, muscle mass, and alteration in tissue water distribution (edema), respectively, were assessed with a chemical shift-encoded Dixon sequence and multiecho spin-echo sequence. Longitudinal within-group and between-group changes were assessed with paired-samples t tests and multivariable regression models. Results A total of 27 patients with DM1 (15 men) were evaluated. Patient age was comparable between groups (intervention, 45 years ± 13 [standard deviation]; standard care, 5 years ± 12; P = .96). Muscle CSA increased 5.9 cm2 ± 7.8 in the intervention group during the 10-month follow-up (P = .03) and decreased 3.6 cm2 ± 7.2 in the standard care group (P = .13). After 10 months, the mean difference between the groups was 9.5 cm2 (P = .01). This effect was stronger in muscles with baseline FF below the mean ± standard deviation of unaffected volunteers (-0.4 cm2 ± 0.15; P < .001). FF increased 0.9% ± 1.0 in the intervention group (P = .02) and 1.2% ± 1.2 for standard care (P = .02), with no between-group difference (P = .56). T2water did not change significantly in either group (intervention, P = .08; standard care, P = .88). Conclusion A behavioral intervention targeting physical activity increased lower extremity muscle cross-sectional area in patients with myotonic dystrophy, preferentially in healthy-appearing muscle. © RSNA, 2020 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2020        PMID: 32808888     DOI: 10.1148/radiol.2020192518

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

1.  Quantitative water T2 relaxometry in the early detection of neuromuscular diseases: a retrospective biopsy-controlled analysis.

Authors:  Noah Locher; Benedikt Wagner; Fabian Balsiger; Olivier Scheidegger
Journal:  Eur Radiol       Date:  2022-05-21       Impact factor: 5.315

2.  Fast Open-Source Toolkit for Water T2 Mapping in the Presence of Fat From Multi-Echo Spin-Echo Acquisitions for Muscle MRI.

Authors:  Francesco Santini; Xeni Deligianni; Matteo Paoletti; Francesca Solazzo; Matthias Weigel; Paulo Loureiro de Sousa; Oliver Bieri; Mauro Monforte; Enzo Ricci; Giorgio Tasca; Anna Pichiecchio; Niels Bergsland
Journal:  Front Neurol       Date:  2021-02-26       Impact factor: 4.003

Review 3.  Overview of MR Image Segmentation Strategies in Neuromuscular Disorders.

Authors:  Augustin C Ogier; Marc-Adrien Hostin; Marc-Emmanuel Bellemare; David Bendahan
Journal:  Front Neurol       Date:  2021-03-25       Impact factor: 4.003

4.  Surface Electromyography Thresholds as a Measure for Performance Fatigability During Incremental Cycling in Patients With Neuromuscular Disorders.

Authors:  Nicoline B M Voet; Christiaan G J Saris; Dick H J Thijssen; Vincent Bastiaans; David E Sluijs; Mariska M H P Janssen
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.